Pharmaceutical Intermediate Chemicals

Linagliptin Intermediate/linagliptin/intermediate
188111-79-7 loss on drying not more than 0.5% 0.2% purity(ee) not less than 98.0% 99.9% ...
Saxagliptin/intermediate/saxagliptin Intermediate
361442-00-4 appearance off-white crystalline powde conforms water(kf) <0.30% 0.20% ...
Linagliptin Intermediate/linagliptin/intermediate
309956-78-3 appearance white powder conforms water(kf) ≤0.5% 0.15% purity(tlc) ≥98.0% ...
Chiral Nematic Liquid Crystals Qypdlc-8
chiral nematic liquid crystals liquid crystal superior to e7 qypdlc-7 qypdlc-8 lower operating temperature tkn(c) -10 -10 upper operating temperature tni(c) ...
2,4-dichloro-3-nitropyridine Cas:5975-12-2
5975/12/2 2,4-二氯-3-硝基吡啶 2,4-dichloro-3-nitropyridine ≥98%
2-methoxy-5-fluorouracil Cas:1480-96-2
1480-96-2 2-甲氧基-5-氟尿嘧啶 2-methoxy-5-fluorouracil ≥98%
N-boc-4-piperidone Cas:79099-07-3
79099-07-3 n-boc-4-哌啶酮 n-boc-4-piperidone ≥98%
4-piperidinemethanol Cas:6457-49-4
6457-49-4 4-哌啶甲醇 4-piperidinemethanol ≥98%
2-bromomethyl-3-nitrobenzoic Acid Methyl Ester
98475-07-1 2-溴甲基-3-硝基苯甲酸甲酯 2-bromomethyl-3-nitrobenzoic acid methyl ester ≥99%
Trimethylsulfoxonium Iodide Cas:1774-47-6
1774-47-6 三甲基碘化亚砜 trimethylsulfoxonium iodide ≥99%
Loading... 352
Report Infringement ->
Trade References - Contact Us - About Us - Partners - Success Stories - FAQ - Privacy Policy - 简体中文 - English

©2019 ,
ICP B2-20090026 09074561